Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Cipla Limited
CIPLACipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India. Address: Cipla House, Mumbai, India, 400013
Analytics
Preço Alvo de Wall Street
123 445.22 INRRácio P/E
28.3376Rendimento de dividendos
0.83 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave CIPLA
Análise de Dividendos CIPLA
Crescimento de dividendos em 5 anos
183 %Crescimento contínuo
1 anoTaxa de pagamento em média de 5 anos
16 %Histórico de Dividendos CIPLA
Avaliação de ações CIPLA
Relatório CIPLA
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |